Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +10.00% | -5.86% | -37.24% |
13/05 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
09/05 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.24% | 240M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.33% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Sector Update: Health Care Stocks Decline with Broader Markets